Richtech Robotics Inc. Under Investigation After 20% Stock Drop
Businesswire· 2026-01-29 23:36
Additionally, Hunterbrook claims that just weeks earlier, Richtech Robotics missed its extended 10-K filing deadline. According to Hunterbrook, Richtech Robotics filed an NT 10-K (notification of late filing) in December 2025, which seemingly delayed its 10-K filing deadline to January 13, 2026. However, Richtech Robotics did not file the 10-K until seven days after the extended deadline, on January 20, 2026. As a result, Hunterbrook questions whether Richtech Robotics may have received a deficiency notice ...
Apple Posts Blowout iPhone Sales, but Investors Focus on Higher Costs
WSJ· 2026-01-29 23:35
Core Viewpoint - The company exceeded its strong forecast, but there are concerns among investors regarding its ability to manage higher costs [1] Group 1 - The company demonstrated robust performance by surpassing its previously strong forecast [1] - Investors are expressing worries about the potential impact of rising costs on the company's future performance [1]
US judge tosses lawsuit accusing J&J of fraud over talc bankruptcy strategy
Reuters· 2026-01-29 23:32
Core Viewpoint - A U.S. district judge dismissed a lawsuit against Johnson & Johnson, which alleged that the company committed fraud by using a shell company's bankruptcy to settle numerous lawsuits related to its baby powder and talc products causing cancer [1] Group 1 - The lawsuit claimed that Johnson & Johnson attempted to resolve tens of thousands of lawsuits through fraudulent means [1] - The judge's dismissal indicates a legal victory for Johnson & Johnson in the ongoing litigation concerning its talc products [1]
Tesla CEO Elon Musk doubles down on robots
Youtube· 2026-01-29 23:32
My next guest says this is a burning the ships moment for the company making a profound working a profound shift away from electric vehicles. George Gina Canacord Genuity managing director joining us now. George um I love that imagery was very Game of Thrones view um that you know he's kind of burning the ships moving ahead into the brave new future.You know Musk himself has said for a long time we are not a car company. That's not why you should own us. That's not what we are.Does this make the moment that ...
OSI (OSIS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2026-01-29 23:31
Core Insights - OSI Systems reported revenue of $464.06 million for the quarter ended December 2025, marking a year-over-year increase of 10.5% and exceeding the Zacks Consensus Estimate by 2.71% [1] - The earnings per share (EPS) for the same period was $2.58, compared to $2.42 a year ago, with an EPS surprise of 2.38% over the consensus estimate of $2.52 [1] Revenue Performance - Healthcare division revenue was $36.53 million, which is 18.6% lower year-over-year and below the average estimate of $44.79 million [4] - Intersegment eliminations reported a revenue of $-19.73 million, a 25.2% year-over-year increase, but worse than the average estimate of $-16.68 million [4] - Optoelectronics and Manufacturing division revenue was $112.55 million, exceeding the average estimate of $107.46 million with an 11.7% year-over-year increase [4] - Security division revenue reached $334.71 million, surpassing the average estimate of $318.69 million and showing a 15.4% year-over-year increase [4] Operating Income Analysis - Non-GAAP operating income for the Security Division was $59.64 million, slightly above the average estimate of $59.53 million [4] - Non-GAAP operating loss for Corporate/Elimination was $-9.52 million, better than the average estimate of $-10.24 million [4] - Non-GAAP operating income for the Healthcare Division was $0.53 million, below the average estimate of $2.34 million [4] - Non-GAAP operating income for the Optoelectronics and Manufacturing Division was $14.49 million, exceeding the average estimate of $13.88 million [4] Stock Performance - OSI shares have returned +6.4% over the past month, outperforming the Zacks S&P 500 composite's +0.8% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]
Axos Financial (AX) Beats Q2 Earnings and Revenue Estimates
ZACKS· 2026-01-29 23:31
Core Viewpoint - Axos Financial reported strong quarterly earnings, exceeding expectations and showing significant year-over-year growth in both earnings and revenues [1][2]. Financial Performance - Quarterly earnings were $2.25 per share, surpassing the Zacks Consensus Estimate of $2.07 per share, and up from $1.82 per share a year ago, representing an earnings surprise of +8.70% [1]. - Revenues for the quarter ended December 2025 were $385.09 million, exceeding the Zacks Consensus Estimate by 11.99% and up from $307.9 million year-over-year [2]. Market Performance - Axos Financial shares have increased approximately 6.6% since the beginning of the year, outperforming the S&P 500, which gained 1.9% [3]. Future Outlook - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $2.05 for the next quarter and $8.23 for the current fiscal year [4][7]. - The Zacks Rank for Axos Financial is 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6]. Industry Context - The Financial - Miscellaneous Services industry, to which Axos Financial belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a favorable environment for performance [8].
Weyerhaeuser (WY) Reports Q4 Loss, Misses Revenue Estimates
ZACKS· 2026-01-29 23:31
Core Viewpoint - Weyerhaeuser reported a quarterly loss of $0.09 per share, better than the Zacks Consensus Estimate of a loss of $0.13, representing an earnings surprise of +28.40% [1] Financial Performance - The company posted revenues of $1.54 billion for the quarter ended December 2025, missing the Zacks Consensus Estimate by 2.73%, compared to year-ago revenues of $1.71 billion [2] - Over the last four quarters, Weyerhaeuser has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - Weyerhaeuser shares have increased by about 10% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] - The current status translates into a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the coming quarter is -$0.02 on $1.68 billion in revenues, and $0.22 on $7.02 billion in revenues for the current fiscal year [7] - The estimate revisions trend for Weyerhaeuser was mixed ahead of the earnings release, which could change following the recent report [6] Industry Context - The Building Products - Wood industry is currently in the bottom 7% of the Zacks industries, indicating potential challenges for stock performance [8] - Another company in the same industry, Potlatch, is expected to report a quarterly loss of $0.12 per share, reflecting a year-over-year change of -271.4% [9]
ResMed (RMD) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2026-01-29 23:31
Core Insights - ResMed reported $1.42 billion in revenue for the quarter ended December 2025, marking an 11% year-over-year increase and a 2.3% surprise over the Zacks Consensus Estimate of $1.39 billion [1] - The earnings per share (EPS) for the same period was $2.81, compared to $2.43 a year ago, resulting in a 4.59% surprise over the consensus EPS estimate of $2.69 [1] Financial Performance Metrics - U.S., Canada, and Latin America - Devices revenue was $448 million, exceeding the estimated $441.42 million, reflecting an 8.1% year-over-year increase [4] - U.S., Canada, and Latin America - Masks and other revenue reached $387 million, surpassing the average estimate of $367.97 million, with a year-over-year change of 15.7% [4] - Combined Europe, Asia, and other markets - Total revenue was $420.9 million, above the estimated $408.04 million, showing an 11.8% year-over-year increase [4] - Combined Europe, Asia, and other markets - Devices revenue was $278.2 million, slightly above the estimated $275.44 million, with a 9.2% year-over-year change [4] - Combined Europe, Asia, and other markets - Masks and other revenue was $142.7 million, exceeding the average estimate of $132.59 million, reflecting a 17.2% year-over-year increase [4] - U.S., Canada, and Latin America - Total revenue was $835 million, surpassing the estimated $809.39 million, with an 11.5% year-over-year change [4] - Global revenue for Total Sleep and Breathing Health was $1.26 billion, exceeding the estimated $1.2 billion, marking an 11.6% year-over-year increase [4] - Global revenue for Residential Care Software was $166.9 million, slightly below the average estimate of $167.55 million [4] - Global revenue for Total Devices was $726.2 million, exceeding the estimated $716.86 million, with an 8.5% year-over-year change [4] - Global revenue for Total Masks and other was $529.7 million, surpassing the estimated $500.57 million, reflecting a 16.1% year-over-year increase [4] Stock Performance - ResMed shares have returned +7% over the past month, outperforming the Zacks S&P 500 composite's +0.8% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]
Redwood Trust Announces Dividend Distribution Tax Information for 2025
Businesswire· 2026-01-29 23:30
MILL VALLEY, Calif.--(BUSINESS WIRE)--Redwood Trust, Inc. (NYSE: RWT, "Redwood†or the "Company†), a leader in expanding access to housing for homebuyers and renters, today announced tax information regarding its dividend distributions for 2025. Shareholders should check the tax statements they receive from their brokerage firms to confirm the Redwood dividend distribution information reported in those statements conforms to the information reported here. Set forth in this press release are Redwood's expec ...
Columbia Financial, Inc. Announces Promotion of Dennis E. Gibney to First Senior Executive Vice President and Chief Banking Officer
Globenewswire· 2026-01-29 23:30
Core Viewpoint - Columbia Financial, Inc. has announced the promotion of Dennis E. Gibney to First Senior Executive Vice President and Chief Banking Officer, while Thomas Splaine, Jr. has been appointed as Executive Vice President and Chief Financial Officer [1][5]. Group 1: Leadership Changes - Dennis E. Gibney has been promoted to First Senior Executive Vice President and Chief Banking Officer, effective immediately [1]. - Thomas Splaine, Jr. has been appointed as Executive Vice President and Chief Financial Officer, also effective immediately [1][5]. Group 2: Responsibilities and Experience - In his new role, Mr. Gibney will oversee finance, credit, special assets, legal, commercial banking, consumer banking, and technology functions [2]. - Mr. Gibney joined the Company in 2014 and has played a significant role in its growth, including expanding the asset base from $5 billion to over $10 billion and completing four acquisitions in five years [3][4]. - Mr. Splaine has over 35 years of experience in banking and finance, previously serving as Executive Vice President and Chief Financial Officer at Lakeland Bancorp, Inc. [4]. Group 3: Company Overview - Columbia Financial, Inc. is a Delaware corporation and the mid-tier holding company for Columbia Bank, which operates 71 full-service banking offices [5].